STAT+: J&J’s new CAR-T therapy shows long-term success, data show
By the time patients with multiple myeloma have gone through four or five different therapies,…
Category: cancer
STAT+: Mutations tied to blood cancers and other diseases may surprisingly protect against Alzheimer’s
ATLANTA — When key mutations strike bone marrow stem cells, known as hematopoietic stem cells,…
STAT+: Roche two-armed antibody posts strong tumor responses in lymphoma study, rivaling CAR-T therapy
An off-the-shelf bispecific antibody developed by Roche induced high and durable response rates in patients…
STAT+: Gilead, Bristol jaw over the superiority of rival CAR-T treatments for blood cancer
Competing, bespoke CAR-T cell therapies from Gilead Sciences and Bristol Myers Squibb have each demonstrated…
In a merger of opposites, City of Hope to buy Cancer Treatment Centers of America for $390 million
City of Hope, the Los Angeles-based nonprofit hospital system, said Wednesday that it will purchase…
Is cancer biology research reproducible? After a decade of work, the answer still isn’t clear
Replication is something of a litmus test for scientific truth, and cancer biologists at the…
STAT+: Liquid biopsies could help screen for countless cancers. But who should get them?
By the time cancer is discovered, it’s often too late to change its course. Close…
STAT+: Immunogen study achieves primary goal of shrinking tumors in patients with ovarian cancer
An antibody treatment that delivers a targeted dose of chemotherapy directly to cancer cells shrank…
STAT+: Injecting cancer patients with genetically engineered viruses could be a ‘rock star’ therapy. Why hasn’t it taken off?
Stacy Erholtz had run out of options. At the age of 49, she had already…
With winter looming, cancer patients and doctors seek more Covid protection
Michele Nadeem-Baker is steeling herself for another winter. Diagnosed with chronic lymphocytic leukemia in 2012,…
Ask Tufts Experts: Evolving Dietary Advice; Nutrition and COVID-19
I do my best to keep up with the latest nutrition advice, but it seems…
STAT+: Big data is the next frontier for biotech — and they’re scrambling for data scientists
Nikhil Munshi’s lab at the Dana-Farber Cancer Institute has accumulated an overwhelming amount of data…
STAT+: Gilead licenses cancer drugs from Arcus in potentially lucrative but risky bet on its cancer business
Gilead Sciences said Thursday that it has exercised an option to license four cancer drugs…
The U.K. is on its way to eliminating cervical cancer. Here’s why the U.S. isn’t close
A decade ago, a London cancer prevention researcher predicted that the United Kingdom’s national HPV…
STAT+: A controversial drug for premature births, which FDA wants withdrawn, is tied to elevated cancer risk
The key ingredient in a controversial medicine used to prevent premature births is associated with a…
STAT+: Hospitals charge insurers and cash-paying patients much more than what Medicare pays for some infused drugs
Nearly a dozen of the highest-rated hospitals in the U.S. charged commercial health insurers and…
STAT+: More lung cancer patients see tumor responses with Mirati’s KRAS combination treatment
Mirati Therapeutics said Monday that more than 60% of patients with lung cancer showed confirmed…
STAT+: CAR-T therapies from Bristol, Gilead superior to standard treatment in blood cancer, studies show
Administering bespoke CAR-T cell therapies from Bristol Myers Squibb or Gilead Sciences provides greater benefit…
Vitamin D and Your Health: Unanswered Questions
If you take supplements in an effort to raise your blood levels of vitamin D,…
Newsbites: Activity and cardiovascular health; produce and cognitive health; caution with vitamin E and beta-carotene
Metabolically Healthy Obesity” May Not Protect Against Heart Disease If you are obese but all…
Virtual Event: Bispecifics: the next weapon against cancer
Editor’s note: A livestream of the conversation will be embedded below at 2 p.m. ET….
STAT+: Rafael Pharma drug fails to prolong survival of patients with pancreatic cancer in large study
Rafael Pharmaceuticals said Thursday that its experimental treatment for pancreatic cancer failed to prolong the…
The vast majority of genes have been tied to cancer — and that can complicate research
João Pedro de Magalhães scours the human genome for clues that might help us understand…
STAT+: 6 things to know before the readout of Rafael Pharma’s pancreatic cancer drug study
Pancreatic cancer is hard to detect early and notoriously resistant to treatment, making it the…
STAT+: In research on mice, scientists use light to paint to a more precise target for CAR-T to attack tumors
In a dark lab, a sedated mouse laid face down on the counter, its backside…
STAT+: Illumina will launch Grail’s cancer detection test in Africa and Asia — but doesn’t know when
Sequencing company Illumina is planning to launch Galleri — the much-hyped cancer detection test from…
STAT+: Takeda strikes a rebate deal for lung cancer drug as health plans look to value-based agreements
In another bid to address the cost of prescription medicines, Takeda Pharmaceuticals (TAK) and 32PointHealth…
Irisin May Have a Future as Treatment to Reduce Brain Inflammation, Preserve Memory
The protective benefits of regular exercise on cognition are well established, but researchers are still…
Black women die earlier and more often of breast cancer. Should they be screened sooner?
For years, health experts have recommended that, starting at the age of 50, every woman…
STAT+: MD Anderson hit with ethics complaint over failure to disclose clinical trial results
An advocacy group has filed an ethics complaint with the University of Texas MD Anderson…
Virtual event: CAR-T comes of age?
Editor’s note: A livestream of this event will be embedded below at 1 p.m. ET. …
STAT+: FDA halts Allogene blood cancer trials after patient found to have ‘chromosomal abnormality’
Allogene Therapeutics said Thursday that the Food and Drug Administration had placed a hold on…
Ask the Doctor: October 2021
Q. What is the difference between a sign and a symptom? A. A symptom is…
Focal Therapy for Prostate Cancer
Not that long ago, the go-to treatment for breast cancer was mastectomy, meaning total removal…
Insomnia Can Be Especially Harmful to Older Adults
Tossing and turning throughout the night, difficulty falling asleep, and nonrestorative sleep are all hallmarks…
Use Food to Fight Goiter
The thyroid gland may be small, but it’s incredibly important, affecting almost every organ in…
Opinion: Enough pink: We’re doing Breast Cancer Awareness Month all wrong
October is upon us, which means the world is about get a whole lot more…
STAT+: Genetic information can be messy. Mapping proteins could offer a clearer view of what’s driving cancer
Scientists have unveiled new maps of the protein networks underlying different types of cancer, offering…
How To Treat Anal Fissures Safely & Effectively
You are starting a bowel movement and you suddenly feel a sharp pain in your…
The Effect of Alcohol on the Digestive System: Does Alcohol Cause Cancer?
Alcohol is the most commonly used drug in the world. When you drink alcohol, it…
.jpg)
Opinion: Proposals to cap Medicare Part B payments will limit outpatient access to CAR-T
The revolutionary life-extending approach to treating cancer known as CAR-T is under threat from a…
Several Options Can Relieve Vaginal Dryness and Revive Your Sex Life
The hormone changes that occur during and after menopause often are accompanied by unwelcome changes…
Check Ingredients When Choosing Anti-Aging Skin Care Products
In a society that places a high value on a youthful appearance, the fine lines,…
Don’t Put Off Doctor’s Visits
We are now well into the second year of the coronavirus, and, thanks in part…
Ask Tufts Experts: Steel Cut vs. Rolled Oats; “Net Carbs” Explained
Why are steel-cut oats preferrable to rolled oats? They can’t be used for baking, take…
STAT+: Pharmalittle: J&J says its Covid-19 shot is more effective in two doses; India plans to resume Covid-19 vaccine exports
Top of the morning to you, and a fine one it is. Sunny skies and…
STAT+: Is a Beyondspring drug helping lung cancer patients live longer? Study results trigger debate
Beyondspring’s stock price tripled in August after the New York drug maker said its experimental…
STAT+: With new colon cancer study results, Mirati lays claim to best KRAS-blocking drug
A drug from Mirati Therapeutics designed to block the cancer protein called KRAS shrank tumors…
STAT+: Pharmalittle: FDA scientists skeptical on boosters; moderate Democrats sink Pelosi’s drug pricing proposal
Good morning, all, I hope everyone is off to a good start. Ed is out…
STAT+: Amgen combination treatment with KRAS-blocking drug shows improved response in colon cancer patients
A combination treatment that pairs Amgen’s KRAS-blocking drug Lumakras with another of its targeted cancer…